GCC countries to explore digital pathology platforms for cancer diagnostics

India-based Medical AI software company Crosscope Inc. partners with Waleed Pharmacy & Stores LLC an Omar Zawawi Establishment (OMZEST) group company focused on bringing healthcare, hospital, and pharmaceutical solutions to Oman.

Crosscope, the provider of AI-enabled digital pathology software signed a Memorandum of Understanding (MoU) with Waleed Pharmacy to enable next-generation transformation in the Histopathology Landscape using Crosscope AI-enabled digital pathology platform. The partnership aims to improve the cancer diagnostics landscape in the region.

The partnership aims to bring state-of-the-art technological solutions to Oman as a comprehensive Digital Pathology Platform using AI, and ML tools for cancer diagnostic service. Integrated and highly flexible workflow solutions are managed by Crosscope Dx, a workflow integrated vendor-agnostic digital pathology platform that offers end-to-end digital pathology solutions with advanced workflow features.

“Waleed Pharmacy’s experienced team has a proven track record of delivering and deploying healthcare IT solutions in the Oman region. We have created the synergies to boost the development and commercialization of our digital pathology workflows,” said Dr. Jayendra Shinde, CEO of Crosscope.

Crosscope also intends to work with the leading key opinion leaders of the region in esteemed hospitals, clinical institutions, diagnostic chains, R&D Labs, research organizations, pharma companies, and other organizations in the related space where the company’s products bring clinical value to the users.

“The joint force we will bring best in class Health IT solutions around the world to the GCC countries beginning & concentrating primarily in Oman.” says Pawan Mordani, General Manager for Waleed Pharmacy. The partnership is expected to reduce the cancer disease burden and improve the overall health structure in Oman.